Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> WHO Considers if Monkeypox Constitutes a Global Health Emergency 23/06/2022 Raisa Santos & Elaine Ruth Fletcher A World Health Organization emergency committee met Thursday to determine if the monkeypox outbreak spreading in non-endemic countries constitutes a Public Health Emergency of International Concern (PHEIC). The closed door meeting, including 16 committee members and eight advisors, will make a recommendation to WHO Director-General Dr Tedros Adhanom Ghebreyesus, who will decide whether to designate […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Effective Treatment and Potential Cure for Hepatitis D – Results Disclosed at International Liver Congress 23/06/2022 Editorial team The drug Bulevirtide can successfully treat and even potentially cure Hepatitis D – the most acute diseases of the hepatitis family and hardest to treat until now, according to the results of a Phase III trial of the drug announced on Thursday, the opening day of the International Liver Congress 2022 (ILC 2022). An estimated 12 […] Continue reading -> Gavi Launches $100m Initiative to Reach Unvaccinated Children 21/06/2022 Raisa Santos A new $100 million initiative to identify and reach zero-dose children – those who have not received a single routine vaccine shot – has been launched today by Gavi, The Vaccine Alliance in partnership with the International Rescue Committee (IRC) and World Vision (WV). The Zero-Dose Immunization Programme (ZIP) will be led by the International […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts
Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> WHO Considers if Monkeypox Constitutes a Global Health Emergency 23/06/2022 Raisa Santos & Elaine Ruth Fletcher A World Health Organization emergency committee met Thursday to determine if the monkeypox outbreak spreading in non-endemic countries constitutes a Public Health Emergency of International Concern (PHEIC). The closed door meeting, including 16 committee members and eight advisors, will make a recommendation to WHO Director-General Dr Tedros Adhanom Ghebreyesus, who will decide whether to designate […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Effective Treatment and Potential Cure for Hepatitis D – Results Disclosed at International Liver Congress 23/06/2022 Editorial team The drug Bulevirtide can successfully treat and even potentially cure Hepatitis D – the most acute diseases of the hepatitis family and hardest to treat until now, according to the results of a Phase III trial of the drug announced on Thursday, the opening day of the International Liver Congress 2022 (ILC 2022). An estimated 12 […] Continue reading -> Gavi Launches $100m Initiative to Reach Unvaccinated Children 21/06/2022 Raisa Santos A new $100 million initiative to identify and reach zero-dose children – those who have not received a single routine vaccine shot – has been launched today by Gavi, The Vaccine Alliance in partnership with the International Rescue Committee (IRC) and World Vision (WV). The Zero-Dose Immunization Programme (ZIP) will be led by the International […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts
European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> WHO Considers if Monkeypox Constitutes a Global Health Emergency 23/06/2022 Raisa Santos & Elaine Ruth Fletcher A World Health Organization emergency committee met Thursday to determine if the monkeypox outbreak spreading in non-endemic countries constitutes a Public Health Emergency of International Concern (PHEIC). The closed door meeting, including 16 committee members and eight advisors, will make a recommendation to WHO Director-General Dr Tedros Adhanom Ghebreyesus, who will decide whether to designate […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Effective Treatment and Potential Cure for Hepatitis D – Results Disclosed at International Liver Congress 23/06/2022 Editorial team The drug Bulevirtide can successfully treat and even potentially cure Hepatitis D – the most acute diseases of the hepatitis family and hardest to treat until now, according to the results of a Phase III trial of the drug announced on Thursday, the opening day of the International Liver Congress 2022 (ILC 2022). An estimated 12 […] Continue reading -> Gavi Launches $100m Initiative to Reach Unvaccinated Children 21/06/2022 Raisa Santos A new $100 million initiative to identify and reach zero-dose children – those who have not received a single routine vaccine shot – has been launched today by Gavi, The Vaccine Alliance in partnership with the International Rescue Committee (IRC) and World Vision (WV). The Zero-Dose Immunization Programme (ZIP) will be led by the International […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts
Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> WHO Considers if Monkeypox Constitutes a Global Health Emergency 23/06/2022 Raisa Santos & Elaine Ruth Fletcher A World Health Organization emergency committee met Thursday to determine if the monkeypox outbreak spreading in non-endemic countries constitutes a Public Health Emergency of International Concern (PHEIC). The closed door meeting, including 16 committee members and eight advisors, will make a recommendation to WHO Director-General Dr Tedros Adhanom Ghebreyesus, who will decide whether to designate […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Effective Treatment and Potential Cure for Hepatitis D – Results Disclosed at International Liver Congress 23/06/2022 Editorial team The drug Bulevirtide can successfully treat and even potentially cure Hepatitis D – the most acute diseases of the hepatitis family and hardest to treat until now, according to the results of a Phase III trial of the drug announced on Thursday, the opening day of the International Liver Congress 2022 (ILC 2022). An estimated 12 […] Continue reading -> Gavi Launches $100m Initiative to Reach Unvaccinated Children 21/06/2022 Raisa Santos A new $100 million initiative to identify and reach zero-dose children – those who have not received a single routine vaccine shot – has been launched today by Gavi, The Vaccine Alliance in partnership with the International Rescue Committee (IRC) and World Vision (WV). The Zero-Dose Immunization Programme (ZIP) will be led by the International […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> WHO Considers if Monkeypox Constitutes a Global Health Emergency 23/06/2022 Raisa Santos & Elaine Ruth Fletcher A World Health Organization emergency committee met Thursday to determine if the monkeypox outbreak spreading in non-endemic countries constitutes a Public Health Emergency of International Concern (PHEIC). The closed door meeting, including 16 committee members and eight advisors, will make a recommendation to WHO Director-General Dr Tedros Adhanom Ghebreyesus, who will decide whether to designate […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Effective Treatment and Potential Cure for Hepatitis D – Results Disclosed at International Liver Congress 23/06/2022 Editorial team The drug Bulevirtide can successfully treat and even potentially cure Hepatitis D – the most acute diseases of the hepatitis family and hardest to treat until now, according to the results of a Phase III trial of the drug announced on Thursday, the opening day of the International Liver Congress 2022 (ILC 2022). An estimated 12 […] Continue reading -> Gavi Launches $100m Initiative to Reach Unvaccinated Children 21/06/2022 Raisa Santos A new $100 million initiative to identify and reach zero-dose children – those who have not received a single routine vaccine shot – has been launched today by Gavi, The Vaccine Alliance in partnership with the International Rescue Committee (IRC) and World Vision (WV). The Zero-Dose Immunization Programme (ZIP) will be led by the International […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts
WHO Considers if Monkeypox Constitutes a Global Health Emergency 23/06/2022 Raisa Santos & Elaine Ruth Fletcher A World Health Organization emergency committee met Thursday to determine if the monkeypox outbreak spreading in non-endemic countries constitutes a Public Health Emergency of International Concern (PHEIC). The closed door meeting, including 16 committee members and eight advisors, will make a recommendation to WHO Director-General Dr Tedros Adhanom Ghebreyesus, who will decide whether to designate […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Effective Treatment and Potential Cure for Hepatitis D – Results Disclosed at International Liver Congress 23/06/2022 Editorial team The drug Bulevirtide can successfully treat and even potentially cure Hepatitis D – the most acute diseases of the hepatitis family and hardest to treat until now, according to the results of a Phase III trial of the drug announced on Thursday, the opening day of the International Liver Congress 2022 (ILC 2022). An estimated 12 […] Continue reading -> Gavi Launches $100m Initiative to Reach Unvaccinated Children 21/06/2022 Raisa Santos A new $100 million initiative to identify and reach zero-dose children – those who have not received a single routine vaccine shot – has been launched today by Gavi, The Vaccine Alliance in partnership with the International Rescue Committee (IRC) and World Vision (WV). The Zero-Dose Immunization Programme (ZIP) will be led by the International […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts
Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Effective Treatment and Potential Cure for Hepatitis D – Results Disclosed at International Liver Congress 23/06/2022 Editorial team The drug Bulevirtide can successfully treat and even potentially cure Hepatitis D – the most acute diseases of the hepatitis family and hardest to treat until now, according to the results of a Phase III trial of the drug announced on Thursday, the opening day of the International Liver Congress 2022 (ILC 2022). An estimated 12 […] Continue reading -> Gavi Launches $100m Initiative to Reach Unvaccinated Children 21/06/2022 Raisa Santos A new $100 million initiative to identify and reach zero-dose children – those who have not received a single routine vaccine shot – has been launched today by Gavi, The Vaccine Alliance in partnership with the International Rescue Committee (IRC) and World Vision (WV). The Zero-Dose Immunization Programme (ZIP) will be led by the International […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts
Effective Treatment and Potential Cure for Hepatitis D – Results Disclosed at International Liver Congress 23/06/2022 Editorial team The drug Bulevirtide can successfully treat and even potentially cure Hepatitis D – the most acute diseases of the hepatitis family and hardest to treat until now, according to the results of a Phase III trial of the drug announced on Thursday, the opening day of the International Liver Congress 2022 (ILC 2022). An estimated 12 […] Continue reading -> Gavi Launches $100m Initiative to Reach Unvaccinated Children 21/06/2022 Raisa Santos A new $100 million initiative to identify and reach zero-dose children – those who have not received a single routine vaccine shot – has been launched today by Gavi, The Vaccine Alliance in partnership with the International Rescue Committee (IRC) and World Vision (WV). The Zero-Dose Immunization Programme (ZIP) will be led by the International […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts
Gavi Launches $100m Initiative to Reach Unvaccinated Children 21/06/2022 Raisa Santos A new $100 million initiative to identify and reach zero-dose children – those who have not received a single routine vaccine shot – has been launched today by Gavi, The Vaccine Alliance in partnership with the International Rescue Committee (IRC) and World Vision (WV). The Zero-Dose Immunization Programme (ZIP) will be led by the International […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts
Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> Posts navigation Older postsNewer posts